Literature DB >> 26593765

[Impact of an infectious diseases consultation service on the quality of care and the survival of patients with infectious diseases].

Siegbert Rieg1, Marc Fabian Küpper2.   

Abstract

While trained infectious diseases (ID) specialists are regularly involved in inpatient and outpatient care in the United States and Canada, these specialized services are only rarely established in Germany. This article aims to summarize the findings of numerous studies that investigated the impact of ID consultation services on patient care and outcome in patients suffering from infectious diseases. The strongest evidence for a clinical benefit is found in the context of Staphylococcus aureus bacteremia (SAB), where in-hospital- and day-30 mortality was significantly and consistently reduced by about 40% in patients that were evaluated and treated in cooperation with an ID physician. Furthermore, studies revealed that this effect was associated with an improved adherence to standards of care. Newer studies show a reduced length of hospital stay due to ID consultations, especially if patients are evaluated early in the course of their hospital stay. Of note, informal or curbside consultations do not seem to be equivalent to a formal ID consultation with bedside patient evaluation. Studies in other patient groups (solid organ transplant recipients or intensive care unit patients) or in the context of other infections (infective endocarditis, pneumonia, other bloodstream infections) also revealed positive effects of ID consultations. Higher rates of appropriate empirical and targeted antimicrobial treatments and de-escalation strategies due to successful pathogen identification were documented. These modifications resulted in lower treatment costs and decreased antimicrobial resistance development. Although there are methodological limitations in single studies, we consider the consistent and reproducible positive effects of ID consultations shown in studies in different countries and health care systems as convincing evidence for the improved quality of care and treatment outcomes in patients with infectious diseases. Thus, strong consideration should be given to establish ID consultation services in small and medium sized hospitals as well.
Copyright © 2015. Published by Elsevier GmbH.

Entities:  

Keywords:  Bakteriämie; Infectious diseases consultation; Infektiologischer Konsiliardienst; Qualitätsindikator; Staphylococcus aureus; Versorgungsqualität; bacteremia; clinical infectious diseases services; klinische Infektiologie; quality indicator; quality-of-care

Mesh:

Substances:

Year:  2015        PMID: 26593765     DOI: 10.1016/j.zefq.2015.09.008

Source DB:  PubMed          Journal:  Z Evid Fortbild Qual Gesundhwes        ISSN: 1865-9217


  4 in total

Review 1.  Infectious diseases consultations can make the difference: a brief review and a plea for more infectious diseases specialists in Germany.

Authors:  Siegbert Rieg; Marc Fabian Küpper
Journal:  Infection       Date:  2016-02-23       Impact factor: 3.553

2.  Infectious disease services: a survey from four university hospitals in Germany.

Authors:  Siegbert Rieg; Florian Hitzenbichler; Stefan Hagel; Isabelle Suarez; Florian Kron; Bernd Salzberger; Mathias Pletz; Winfried V Kern; Gerd Fätkenheuer; Norma Jung
Journal:  Infection       Date:  2018-08-17       Impact factor: 3.553

3.  Impact of Infectious Disease Consultation in Patients With Candidemia: A Retrospective Study, Systematic Literature Review, and Meta-analysis.

Authors:  Takaaki Kobayashi; Alexandre R Marra; Marin L Schweizer; Patrick Ten Eyck; Chaorong Wu; Mohammed Alzunitan; Jorge L Salinas; Marc Siegel; Dimitrios Farmakiotis; Paul G Auwaerter; Heather S Healy; Daniel J Diekema
Journal:  Open Forum Infect Dis       Date:  2020-08-03       Impact factor: 3.835

4.  The impact of infectious diseases consultation on the management and outcomes of Pseudomonas aeruginosa bacteraemia in adults: a retrospective cohort study.

Authors:  Fabian Chiong; Mohammed S Wasef; Kwee Chin Liew; Raquel Cowan; Danny Tsai; Yin Peng Lee; Larry Croft; Owen Harris; Stella May Gwini; Eugene Athan
Journal:  BMC Infect Dis       Date:  2021-07-09       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.